Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Safe Orthopaedics    SAFOR   FR0012452746

SAFE ORTHOPAEDICS (SAFOR)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsSector newsTweets

Safe Orthopaedics : Franois-Henri Reynaud Appointed as Safe Orthopaedics Chief Financial Officer

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 03:51pm CET

SAFE ORTHOPAEDICS (Paris:SAFOR) (FR0012452746 SAFOR), a company offering innovative ranges of sterile implants combined with their single-use instruments for back surgery, today announces the appointment of Franois-Henri Reynaud as Chief Financial and Administrative Officer.

Franois-Henri has 13 years experience in finance. For five years, he was initially involved in financing innovative business companies in a financial institution, before overseeing several corporate finance transactions (fund-raising transactions, mergers and acquisitions) as Chief Financial and Administrative Officer of companies in a variety of sectors including medical devices and renewable energies. His most recent appointment was at Global Bioenergies, a listed industrial biology company.

Franois-Henri Reynauds main role will be to handle the Companys financial and administrative affairs, working closely with the Chief Executive Officer.

Franois-Henri Reynaud, Safe Orthopaedics new Chief Financial and Administrative Officer, commented: It is a unique opportunity to join Safe Orthopaedics just as the Company has reported an increase in its third-quarter revenues of over 63% year-on-year and is expanding its business worldwide.

Pierre Dumouchel, Chief Executive Officer and Co-founder of Safe Orthopaedics, added: Together with his expertise in finance, Franois-Henris appointment as Chief Financial and Administrative Officer brings to the table his experience of establishing and building up international subsidiaries just as Safe Orthopaedics embarks on a new phase of expansion to accelerate its growth and business development.

Next financial release: full-year 2017 revenues, Monday, January 15, 2018 (after the market closes)

(c) NNA 2017 LEBANON Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SAFE ORTHOPAEDICS
2017SAFE ORTHOPAEDICS : Franois-Henri Reynaud Appointed as Safe Orthopaedics Chief F..
AQ
2017SAFE ORTHOPAEDICS : Researchers Submit Patent Application, "Device and Method fo..
AQ
2017SAFE ORTHOPAEDICS : Patent Issued for Instrument System for Carrying Out a Surgi..
AQ
2017SAFE ORTHOPAEDICS : Offers New Technologies to Treat Traumatic Injuries Due to O..
AQ
2016SAFE ORTHOPAEDICS : Half-year 2016 results
PU
2016SAFE ORTHOPAEDICS : Pierre Dumouchel’s interim appointment as Chief Execut..
PU
2016SAFE ORTHOPAEDICS : expands into Latin America
PU
2016SAFE ORTHOPAEDICS : Monthly information regarding the total number of voting rig..
PU
2016SAFE ORTHOPAEDICS : announces the success of the first surgeries using its new c..
PU
2016SAFE ORTHOPAEDICS : Full-year 2015 results and first-quarter 2016 revenue
PU
More news
Chart SAFE ORTHOPAEDICS
Duration : Period :
Safe Orthopaedics Technical Analysis Chart | SAFOR | FR0012452746 | 4-Traders
Technical analysis trends SAFE ORTHOPAEDICS
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Managers
NameTitle
Pierre Dumouchel Chief Executive Officer
Alain Coudray Chairman
François-Henri Reynaud Chief Financial & Administrative Officer
Thomas Droulout Chief Technology Officer
Michael F. DeMane Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SAFE ORTHOPAEDICS3.92%16
STRYKER CORPORATION0.90%58 471
SMITH & NEPHEW-1.16%15 594
JAPAN LIFELINE CO., LTD.39.75%2 766
WRIGHT MEDICAL GROUP NV-7.61%2 154
GLAUKOS CORP20.90%1 072